Predictors of contralateral prophylactic mastectomy in genetically high risk newly diagnosed breast cancer patients
Authors:
- 1 January 2020
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 180 (1) , 177-185
Abstract
Purpose Recent trends indicate increased use of contralateral prophylactic mastectomy (CPM) among newly diagnosed breast cancer patients, particularly those who test positive for a pathogenic variant in the BRCA1/2 genes. However, the rate of CPM among patients who test negative or choose not to be tested is surprisingly high. We aimed to identify patient predictors of CPM following breast cancer diagnosis among such patients. Methods As part of a randomized controlled trial of rapid genetic counseling and testing vs. usual care, breast cancer patients completed a baseline survey within 6 weeks of diagnosis and before definitive surgery. Analyses focused on patients who opted against testing (n = 136) or who received negative BRCA1/2 test results (n = 149). We used multivariable logistic regression to assess the associations between sociodemographic, clinical- and patient-reported factors with use of CPM. Results Among patients who were untested or who received negative test results, having discussed CPM with one’s surgeon at the time of diagnosis predicted subsequent CPM. Patients who were not candidates for breast-conserving surgery and those with higher levels of cancer-specific intrusive thoughts were also more likely to obtain a CPM. Conclusion The strongest predictors of CPM in this population were objective clinical factors and discussion with providers. However, baseline psychosocial factors were also independently related to the receipt of CPM. Thus, although CPM decisions are largely guided by relevant clinical factors, it is important to attend to psychosocial factors when counseling newly diagnosed breast cancer patients about treatment options.Keywords
Funding Information
- National Cancer Institute (R01 CA74861, P30 CA051008)
- Jess and Mildred Fisher Center for Familial Cancer Research
This publication has 43 references indexed in Scilit:
- Intentions for bilateral mastectomy among newly diagnosed breast cancer patientsJournal of Surgical Oncology, 2012
- Contralateral prophylactic mastectomy in breast cancer patients who test negative for BRCA mutationsThe American Journal of Surgery, 2011
- Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and MortalityJAMA, 2010
- Factors Affecting the Decision of Breast Cancer Patients to Undergo Contralateral Prophylactic MastectomyCancer Prevention Research, 2010
- Contralateral Breast Cancer Risk in BRCA1 and BRCA2 Mutation CarriersJournal of Clinical Oncology, 2009
- Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivorsBreast Cancer Research and Treatment, 2006
- Impact of BRCA1/BRCA2 Counseling and Testing on Newly Diagnosed Breast Cancer PatientsJournal of Clinical Oncology, 2004
- Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study GroupJournal of Clinical Oncology, 2004
- Breast Cancer after Prophylactic Bilateral Mastectomy in Women with aBRCA1orBRCA2MutationNew England Journal of Medicine, 2001
- Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast CancerNew England Journal of Medicine, 1999